Midostaurin is a prescription medicine used to treat adults with newly diagnosed aggressive systemic mastocytosis (ASM) or a condition called mast cell leukemia. It is also used to treat a rare type of blood cancer called advanced systemic mastocytosis (SM-AHNMD) in adults and children 16 years of age and older. Midostaurin helps to control the buildup of mast cells in the body and reduce their activity. It works by blocking enzymes that are responsible for the growth and spread of mast cells.
Midostaurin is a medication used for treating specific types of cancer and a blood disorder. Here's a breakdown of its key points:
Type: Kinase inhibitor [1, 2]
Function: Midostaurin works by blocking the activity of specific enzymes (kinases) involved in the growth and survival of cancer cells and certain immune system cells [1, 3].
Applications:
- Acute Myeloid Leukemia (AML): This is a type of blood cancer. Midostaurin is used in combination with other chemotherapy drugs to treat AML with a specific genetic mutation called FLT3 [1, 2, 4].
- Mastocytosis: This is a blood disorder characterized by an abnormal increase in mast cells (immune system cells). Midostaurin is used for treating aggressive forms of mastocytosis, including systemic mastocytosis with associated hematologic neoplasm (SM-AHN) and mast cell leukemia (MCL) [1, 2, 4].
Important Considerations:
- Midostaurin is a prescription medication and should only be taken under the supervision of a doctor who specializes in treating cancer or blood disorders [1].
- It can cause various side effects, including nausea, vomiting, diarrhea, headache, fatigue, and increased risk of infections [2, 4].
- Midostaurin may interact with other medications, so it's crucial to inform your doctor about all medications you're taking before starting treatment [2, 4].
Brand Names:
- Midostaurin is marketed under the brand name Rydapt [5].
Additional Information:
- Midostaurin is typically administered as capsules taken orally [2].